Marksans Pharma Ltd. - Board Meeting Intimation for To Consider And Approve The Annual Audited Financial Results Of The Company (Both Standalone And Consolidated) For The Financial Year Ended 31St March, 2019. The Board Of Directors Will Also Consider Recommendation Of Dividend, If Any, For The Financial Year 2018-19.

MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2019 ,inter alia, to consider and approve This is to inform you that the Meeting of the Board of Directors of the Company will be held on Wednesday, 29th May, 2019 at Mumbai, to consider and approve the Annual Audited Financial Results of the Company (both Standalone and Consolidated) for the Financial Year ended 31st March, 2019. The Board of Directors will also consider recommendation of dividend, if any, for the Financial Year 2018-19. Please note that as per the Insider Trading Code of the Company, the Trading Window for dealing in Companys shares is closed for the Companys insiders from 3rd April, 2019 and will remain closed till Forty-Eight hours after the announcement of the Financial Results on 29th May, 2019.

Pdf Link: Marksans Pharma Ltd. - Board Meeting Intimation for To Consider And Approve The Annual Audited Financial Results Of The Company (Both Standalone And Consolidated) For The Financial Year Ended 31St March, 2019. The Board Of Directors Will Also Consider Recommendation Of Dividend, If Any, For The Financial Year 2018-19.

Source : BSE - www.bseindia.com

COMMENT NOW